Literature DB >> 415798

Meganeurites and other aberrant processes of neurons in feline GM1-gangliosidosis: a Golgi study.

D P Purpura, H J Baker.   

Abstract

Golgi studies were carried out on neurons in several forebrain structures of young adult mutant cats with inherited beta-galactosidase deficiency and neurobehavioral deterioration due to GM1-ganglioside storage disease. Meganeurites similar to those observed in several human gangliosidoses were present on small and medium pyramidal neurons, granule cells of the fascia dentata and spiny neurons of the caudate nucleus. Large and giant pyramidal cells of the motor cortex exhibited prominent somatic spines but lacked meganeurites. Cortical non-pyramidal neurons and aspiny caudate cells were relatively normal in appearance although they showed variable increases in cell body diameter. The range of morphological alterations in different types of cortical neurons in feline GM1-gangliosidosis was identical to that found in human ganglioside storage diseases. Neurite outgrowth from meganeurites was particularly prominent in the feline mutant. The extensive proliferation of neurites confined to meganeurites indicates that the latter have growth properties typical of embryonic neuronal elements. The demonstration of neurite outgrowth from meganeurites of mature cortical neurons in feline GM1-gangliosidosis suggests a possible role for gangliosides in neurite formation during neuronal differentiation and synaptogenesis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 415798     DOI: 10.1016/0006-8993(78)90749-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  22 in total

Review 1.  Biochemistry and genetics of gangliosidoses.

Authors:  K Sandhoff; H Christomanou
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

2.  Effect of HFE variants on sphingolipid expression by SH-SY5Y human neuroblastoma cells.

Authors:  F Ali-Rahmani; J A Hengst; J R Connor; C-L Schengrund
Journal:  Neurochem Res       Date:  2011-01-18       Impact factor: 3.996

3.  Metabolism of cerebroside sulfate and subcellular distribution of its metabolites in cultured skin fibroblasts from controls, metachromatic leukodystrophy, and globoid cell leukodystrophy.

Authors:  K Inui; M Furukawa; S Okada; H Yabuuchi
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

4.  A Golgi study of the large anterior horn cells of the lumbar cords in normal spinal cords and in amyotrophic lateral sclerosis.

Authors:  T Kato; A Hirano; H Donnenfeld
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

5.  GM2 gangliosidosis in a Japanese spaniel.

Authors:  J F Cummings; P A Wood; S U Walkley; A de Lahunta; M E DeForest
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

6.  A Golgi study of the proximal portion of the human Purkinje cell axon.

Authors:  T Kato; A Hirano
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

7.  Growth of abnormal neurites in atypical Alzheimer's disease. A study with the Golgi method.

Authors:  I Ferrer; A Aymami; A Rovira; J M Grau Veciana
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

8.  Alterations in neuron morphology in feline mannosidosis. A Golgi study.

Authors:  S U Walkley; W F Blakemore; D P Purpura
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

9.  Incorporation of exogenous ganglioside GM1 into neuroblastoma membranes: inhibition by calcium ion and dependence upon membrane protein.

Authors:  K C Leskawa; R E Erwin; A Leon; G Toffano; E L Hogan
Journal:  Neurochem Res       Date:  1989-06       Impact factor: 3.996

10.  Molecular consequences of the pathogenic mutation in feline GM1 gangliosidosis.

Authors:  Douglas R Martin; Brigitte A Rigat; Polly Foureman; G S Varadarajan; Misako Hwang; Barbara K Krum; Bruce F Smith; John W Callahan; Don J Mahuran; Henry J Baker
Journal:  Mol Genet Metab       Date:  2008-03-18       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.